TLRY | Tilray Brands, Inc. Stock Overview

(Stock Exchange: NASDAQ)

Day's Range	1.1600 - 1.2100
52 Week Range	1.1400 - 2.9700
Beta	2.05
Implied Volatility	115.30%
IV Rank	26.97%
Day's Volume	52,537,500
Average Volume	34,693,051
Shares Outstanding	937,655,000
Market Cap	1,097,056,350
Sector	Healthcare
Industry	Drug Manufacturers - Specialty & Generic
IPO Date	2018-07-19

Valuation
Profitability
Growth
Health
P/E Ratio	-3.90
Forward P/E Ratio	-13.32
EPS	-0.30
1YR Price Target	2.25
Dividend Yield	N/A
Dividend Per Share	N/A
Dividend ExDate	N/A
Dividend PayDate	N/A
Employees	2,650
Country	Canada
Website	TLRY

Tilray is a Canadian producer that cultivates and sells medical and recreational cannabis. In 2021, legacy Aphria acquired legacy Tilray in a reverse merger and renamed itself Tilray. The bulk of its sales are in Canada and in the international medical cannabis export market. U.S. exposure consists of CBD products through Manitoba Harvest and beer through SweetWater.

TLRY's peers: ACB, BHC, CGC, CRON, COSM, ZOM, OGI, SNDL, TEVA, HEXO, CURLF, VTRS, SHPH, LFCR

*Chart delayed

Analyzing fundamentals for TLRY we got that it has weak fundamentals where Valuation is considered to be significantly overvalued, Profitability is unacceptably poor, Growth is desperately bad and Health is weak. For more detailed analysis please see TLRY Fundamentals page.

Watching at TLRY technicals we can see that long-term trend is bearish, the same as bearish middle-term trend, as well as bearish short-term trend. More technicals details can be found on TLRY Technicals page.